Literature DB >> 15333746

Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target.

Stephen D Hursting1, Jackie A Lavigne, David Berrigan, Lawrence A Donehower, Barbara J Davis, James M Phang, J Carl Barrett, Susan N Perkins.   

Abstract

Progress in cancer prevention research is being facilitated by the use of animal models displaying specific genetic susceptibilities for cancer, such as mice deficient in one (+/-) or both (-/-) alleles of the p53 tumor suppressor gene. Our lab, which focuses on nutrition (particularly energy balance/obesity) and molecular carcinogenesis, has shown in p53-/- mice that calorie restriction (CR) increases the latency of spontaneous tumor development (mostly lymphomas) approximately 75%, decreases serum insulin-like growth factor (IGF)-1 and leptin levels, and induces apoptosis in immature (lymphoma-susceptible) thymocytes. In heterozygous p53-deficient (p53+/-) mice, CR and a one day/wk fast each significantly delay spontaneous tumor development (a mix of lymphomas, sarcomas, and epithelial tumors) and decreases serum IGF-1 and leptin levels, even when begun late in life. We are presently comparing and combining CR and exercise (treadmill and running wheel) to further elucidate the relationships between energy balance, p53, and tumorigenesis in these models. Furthermore, we have capitalized on the susceptibility of p53+/- mice to chronic, low-dose aromatic amine-induced bladder carcinogenesis to develop a model for evaluating bladder cancer prevention approaches. Using this model, we have established that IGF-1 mediates many of the anti-cancer effects of CR. We are currently conducting oligonucleotide microarray studies to further characterize diet-gene interactions underlying the anti-cancer effects of CR and to determine which of the CR-responsive genes are IGF-1 dependent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333746     DOI: 10.1093/jn/134.9.2482S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  12 in total

1.  The antioxidant function of the p53 tumor suppressor.

Authors:  Anna A Sablina; Andrei V Budanov; Galina V Ilyinskaya; Larissa S Agapova; Julia E Kravchenko; Peter M Chumakov
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

Review 2.  Insulin and IGFs in obesity-related breast cancer.

Authors:  Valentina Belardi; Emily J Gallagher; Ruslan Novosyadlyy; Derek LeRoith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-24       Impact factor: 2.673

3.  Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates.

Authors:  Ilhem Messaoudi; Jessica Warner; Miranda Fischer; Buyng Park; Brenna Hill; Julie Mattison; Mark A Lane; George S Roth; Donald K Ingram; Louis J Picker; Daniel C Douek; Motomi Mori; Janko Nikolich-Zugich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

4.  Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.

Authors:  Federico Canzian; David G Cox; V Wendy Setiawan; Daniel O Stram; Regina G Ziegler; Laure Dossus; Lars Beckmann; Hélène Blanché; Aurelio Barricarte; Christine D Berg; Sheila Bingham; Julie Buring; Saundra S Buys; Eugenia E Calle; Stephen J Chanock; Françoise Clavel-Chapelon; John Oliver L DeLancey; W Ryan Diver; Miren Dorronsoro; Christopher A Haiman; Göran Hallmans; Susan E Hankinson; David J Hunter; Anika Hüsing; Claudine Isaacs; Kay-Tee Khaw; Laurence N Kolonel; Peter Kraft; Loïc Le Marchand; Eiliv Lund; Kim Overvad; Salvatore Panico; Petra H M Peeters; Michael Pollak; Michael J Thun; Anne Tjønneland; Dimitrios Trichopoulos; Rosario Tumino; Meredith Yeager; Robert N Hoover; Elio Riboli; Gilles Thomas; Brian E Henderson; Rudolf Kaaks; Heather Spencer Feigelson
Journal:  Hum Mol Genet       Date:  2010-07-15       Impact factor: 6.150

5.  Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults.

Authors:  David Berrigan; Nancy Potischman; Kevin W Dodd; Stephen D Hursting; Jackie Lavigne; J Carl Barrett; Rachel Ballard-Barbash
Journal:  Growth Horm IGF Res       Date:  2008-09-21       Impact factor: 2.372

Review 6.  Gene expression in the placenta: maternal stress and epigenetic responses.

Authors:  Ciprian P Gheorghe; Ravi Goyal; Ashwani Mittal; Lawrence D Longo
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

7.  Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden.

Authors:  Robin Taylor Wilson; Mark Donahue; Gloria Gridley; Johanna Adami; Laure El Ghormli; Mustafa Dosemeci
Journal:  Am J Ind Med       Date:  2008-02       Impact factor: 2.214

8.  Placental gene expression responses to maternal protein restriction in the mouse.

Authors:  C P Gheorghe; R Goyal; J D Holweger; L D Longo
Journal:  Placenta       Date:  2009-04-11       Impact factor: 3.481

9.  Expression of dominant-negative Dmp53 in the adult fly brain inhibits insulin signaling.

Authors:  Johannes H Bauer; Chengyi Chang; Siti Nur Sarah Morris; Suzanne Hozier; Sandra Andersen; Joshua S Waitzman; Stephen L Helfand
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

10.  Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1.

Authors:  Leticia M Nogueira; Jackie A Lavigne; Gadisetti V R Chandramouli; Huaitian Lui; J Carl Barrett; Stephen D Hursting
Journal:  Cancer Med       Date:  2012-08-06       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.